Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer

Considerable evidence from both clinical and experimental studies suggests that androgen receptor variants, particularly androgen receptor variant 7 (AR-V7), are critical in the induction of resistance to enzalutamide and abiraterone. In this study, we investigated the role of AR-V7 in the cross-res...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chengfei, Armstrong, Cameron, Zhu, Yezi, Lou, Wei, Gao, Allen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078008/
https://www.ncbi.nlm.nih.gov/pubmed/27049719
http://dx.doi.org/10.18632/oncotarget.8493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078008/
https://www.ncbi.nlm.nih.gov/pubmed/27049719
http://dx.doi.org/10.18632/oncotarget.8493

Ejemplares similares